Evidence map›Paper›PMID 34957475›Full record

ArticleBrain : a journal of neurology2022

Nav1.7 is required for normal C-low threshold mechanoreceptor function in humans and mice.

Steven J Middleton, Irene Perini, Andreas C Themistocleous, Greg A Weir, Kirsty McCann, Allison M Barry, Andrew Marshall, Michael Lee, Leah M Mayo, Manon Bohic and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. The psychoactive cannabinoid THC inhibits peripheral nociceptors by targeting NaNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. NaThe Journal of comparative neurology · 2026
    Article
  4. Article
  5. Article
  6. Shaping the Action Potential in Dorsal Root and Trigeminal Ganglia Neurons: Relevance to Pain Mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. NaExperimental neurology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 6 countries.

Steven J MiddletonNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0002-0708-7335
Irene PeriniCenter for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0002-5972-0913
Andreas C ThemistocleousNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
Greg A WeirNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
Kirsty McCannNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
Allison M BarryNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0002-6787-6889
Andrew MarshallInstitute of Aging and Chronic Disease, University of Liverpool, L3 5DA Liverpool, UK.
Michael LeeUniversity Division of Anaesthesia, University of Cambridge, Cambridge NHS Foundation Trust Hospitals, Hills Road, Cambridge CB2 0QQ, UK.
Leah M MayoCenter for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Manon BohicAix-Marseille-Université, CNRS, Institute de Biologie du Développement de Marseille, UMR 7288, case 907, 13288 Marseille Cedex 09, France.
Georgios BaskozosNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
India MorrisonCenter for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Line S LökenDepartment of Physiology, University of Gothenburg, Gothenburg, Sweden.
Sarah McIntyreCenter for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0002-0544-6533
Saad S NagiCenter for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0001-8773-8232
Roland StaudDepartment of Physiological Sciences, University of Florida College of Veterinary Medicine, Gainesville, FL, USA.
Isac SehlstedtDepartment of Psychology, University of Gothenburg, Gothenburg, Sweden.
Richard D JohnsonDepartment of Physiology, University of Gothenburg, Gothenburg, Sweden.
Johan WessbergDepartment of Physiology, University of Gothenburg, Gothenburg, Sweden.
John N WoodMolecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK.
Christopher G WoodsCambridge Institute for Medical Research, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Aziz MoqrichAix-Marseille-Université, CNRS, Institute de Biologie du Développement de Marseille, UMR 7288, case 907, 13288 Marseille Cedex 09, France.
Håkan OlaussonCenter for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
David L BennettNuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
Linköping University · SEUniversity of Oxford · GBUniversity of Gothenburg · SEUniversity of Cambridge · GBUniversity of Florida · USCentre National de la Recherche Scientifique · FRRutgers, The State University of New Jersey · USUniversity College London · GBUniversity of Liverpool · GBUniversity of the Witwatersrand · ZA

Funding

Department of HealthMedical Research Council MR/T01072X/1Medical Research Council MR/T020113/1Medical Research Council MR/W002426/1Versus Arthritis 21950Wellcome Trust 200183/Z/15/ZWellcome Trust 202747/Z/16/Z
6 · The paper itself

Abstract

Patients with bi-allelic loss of function mutations in the voltage-gated sodium channel Nav1.7 present with congenital insensitivity to pain (CIP), whilst low threshold mechanosensation is reportedly normal. Using psychophysics (n = 6 CIP participants and n = 86 healthy controls) and facial electromyography (n = 3 CIP participants and n = 8 healthy controls), we found that these patients also have abnormalities in the encoding of affective touch, which is mediated by the specialized afferents C-low threshold mechanoreceptors (C-LTMRs). In the mouse, we found that C-LTMRs express high levels of Nav1.7. Genetic loss or selective pharmacological inhibition of Nav1.7 in C-LTMRs resulted in a significant reduction in the total sodium current density, an increased mechanical threshold and reduced sensitivity to non-noxious cooling. The behavioural consequence of loss of Nav1.7 in C-LTMRs in mice was an elevation in the von Frey mechanical threshold and less sensitivity to cooling on a thermal gradient. Nav1.7 is therefore not only essential for normal pain perception but also for normal C-LTMR function, cool sensitivity and affective touch.

Indexed as

NAV1.7 Voltage-Gated Sodium ChannelPain Insensitivity, CongenitalAnimalsChannelopathiesHumansMechanoreceptorsMiceSodiumNAV1.7 Voltage-Gated Sodium ChannelSCN9A protein, humanScn9a protein, mouseSodiumaffective touchC-low threshold mechanoreceptorscongenital insensitivity to painNav1.7

Identifiers

PMID34957475
PMCPMC9586547
OpenAlexW4200320754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.